031240110	031240110	CD	B-NP	O
|	|	NN	I-NP	O
NUMC	NUMC	NN	I-NP	O
|	|	NN	I-NP	O
00736162	00736162	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2877011	2877011	CD	B-NP	O
|	|	CC	I-NP	O
1/27/2004	1/27/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/4/2004	11/4/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/25/2004	4/25/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
PITPITAN	PITPITAN	NN	I-NP	O
,	,	,	O	O
CHAS	CHAS	NNP	B-NP	O
869-04-33-0	869-04-33-0	CD	I-NP	O
Asssho	Asssho	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
9/9/04	9/9/04	CD	B-NP	O
AT	AT	NN	I-NP	O
07	07	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LANGBEIN	LANGBEIN	NN	B-NP	O
,	,	,	O	O
GARLAND	GARLAND	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
VENTOLIN	VENTOLIN	NNP	B-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Shortness	Shortness	NN	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
8/25	8/25	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
70	70	CD	B-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
SC	SC	NNP	I-NP	O
60	60	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
70	70	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/9/04	9/9/04	CD	B-NP	O
by	by	IN	B-PP	O
VANABEL	VANABEL	NNP	B-NP	O
,	,	,	O	O
SAMUEL	SAMUEL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ZOCOR	ZOCOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

FLOVENT	FLOVENT	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
44	44	CD	B-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Nico	Nico	NNP	I-NP	O
within	within	IN	B-PP	O
4-6	4-6	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
call	call	NN	B-NP	B-protein
528.615.7818	528.615.7818	CD	B-NP	I-protein
4-6	4-6	CD	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Williams	Williams	NNP	I-NP	O
Dulkis	Dulkis	NNP	I-NP	O
,	,	,	O	O
OTH	OTH	NNP	B-NP	O
,	,	,	O	O
112.517.9201	112.517.9201	CD	B-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
see	see	VB	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Faulker	Faulker	NNP	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
ASTHMA/COPD	ASTHMA/COPD	NNP	I-NP	O
FEV1	FEV1	NNP	I-NP	O
.97	.97	CD	I-NP	O
,	,	,	O	O
FEV1/FVC	FEV1/FVC	NN	B-NP	O
.46	.46	CD	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REQ	REQ	NNP	I-NP	O
TYPE	TYPE	NNP	I-NP	O
II	II	NNP	I-NP	O
DM	DM	NNP	I-NP	O
SEASONAL	SEASONAL	NNP	I-NP	O
RHINITIS	RHINITIS	NNP	I-NP	O
DIVERTICULOSIS	DIVERTICULOSIS	NNP	I-NP	O
NEPHROLITHIASIS	NEPHROLITHIASIS	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
INTUBATION	INTUBATION	NNP	I-NP	O
6/26	6/26	CD	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
7/25/04	7/25/04	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
LAD	LAD	NN	B-NP	O
prox	prox	NN	I-NP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LCX	LCX	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
RCA	RCA	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
R	R	NN	B-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
mid	mid	VBD	B-VP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Conclusion	Conclusion	NN	B-NP	O
:	:	:	O	O
non-obstructive	non-obstructive	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
L	L	NN	I-NP	O
heart	heart	NN	I-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Gerache	Gerache	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
59	59	CD	I-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
diabetes	diabetes	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
few	few	JJ	I-NP	O
weeks	week	NNS	I-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
intermittent	intermittent	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
activity	activity	NN	B-NP	O
,	,	,	O	O
lasting	last	VBG	B-VP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
relieved	relieve	VBN	B-VP	O
with	with	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
climbs	climb	VBZ	B-VP	O
stairs	stair	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
he	he	PRP	B-NP	O
said	say	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
more	more	RBR	B-ADVP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
asthma	asthma	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
because	because	IN	B-PP	O
of	of	IN	I-PP	O
a	a	DT	B-NP	O
finger	finger	NN	I-NP	O
injury	injury	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
told	tell	VBD	B-VP	O
him	him	PRP	B-NP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
chest	chest	JJ	B-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	B-ADJP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
before	before	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
finger	finger	NN	I-NP	O
sticks	stick	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
200-300	200-300	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
ischemia	ischemia	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Wanzer	Wanzer	NNP	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
mor	mor	NN	I-NP	O
ning	ning	NN	I-NP	O
of	of	IN	B-PP	O
10/06	10/06	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
3	3	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	O
enzymes	enzyme	NNS	I-NP	O
-LRB-	-LRB-	JJ	B-NP	O
elevated	elevated	JJ	I-NP	O
CKMB	CKMB	NN	I-NP	B-protein
but	but	CC	O	O
negative	negative	JJ	B-NP	O
troponins	troponin	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
significant	significant	JJ	B-ADJP	O
only	only	RB	B-ADVP	O
for	for	IN	B-PP	O
j	j	NN	B-NP	O
point	point	NN	I-NP	O
elevation	elevation	NN	I-NP	O
diffusely	diffusely	RB	B-ADVP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
beta	beta	SYM	I-NP	O
blocker	blocker	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
-	-	HYPH	B-PRT	O
cholesterol	cholesterol	NN	B-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
elevated	elevate	VBN	I-NP	O
triglycerides	triglyceride	NNS	I-NP	O
308	308	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
146	146	CD	I-NP	O
,	,	,	O	O
HDL	HDL	NN	B-NP	B-protein
29	29	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Baseline	Baseline	NN	B-NP	O
LFTs	LFT	NNS	I-NP	O
checked	check	VBD	B-VP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
statin	statin	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
-	-	HYPH	B-PRT	O
aspirin	aspirin	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
because	because	RB	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
stated	state	VBN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
aspirin	aspirin	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
causes	cause	VBZ	B-VP	O
asthma	asthma	NN	B-NP	B-protein
type	type	NN	I-NP	I-protein
symptoms	symptom	NNS	I-NP	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
-	-	HYPH	B-NP	O
will	will	MD	B-VP	O
start	start	VB	I-VP	O
patient	patient	NN	B-NP	O
on	on	IN	B-PP	O
low-dose	low-dose	JJ	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
PUMP	PUMP	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
prior	prior	JJ	I-NP	O
echo	echo	NN	I-NP	O
,	,	,	O	O
consider	consider	VBP	B-VP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

appears	appear	VBZ	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

rhythm	rhythm	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
-	-	:	O	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
but	but	CC	O	O
rarely	rarely	RB	B-VP	O
checks	check	VBZ	I-VP	O
his	his	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
does	do	VBZ	B-VP	O
it	it	PRP	B-NP	O
's	'	VBZ	B-VP	O
usually	usually	RB	B-ADVP	O
200-300s	200-300s	CD	B-NP	O
.	.	.	O	O

Hemoglobin	Hemoglobin	NN	B-NP	B-protein
A1c	A1c	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
10.7	10.7	CD	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
but	but	CC	O	O
clearly	clearly	RB	B-VP	O
needs	need	VBZ	I-VP	O
better	good	JJR	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
says	say	VBZ	B-VP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
asthma	asthma	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
child	child	NN	I-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
record	record	NN	I-NP	O
of	of	IN	B-PP	O
PFTs	PFT	NNS	B-NP	B-protein
but	but	CC	O	O
should	should	MD	B-VP	O
obtain	obtain	VB	I-VP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

Home	Home	NN	B-NP	B-protein
inhalers	inhaler	NNS	I-NP	I-protein
continued	continue	VBD	B-VP	I-protein
4	4	CD	B-NP	I-protein
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Gaulding	Gaulding	NNP	I-NP	O
currently	currently	RB	B-ADVP	O
has	have	VBZ	B-VP	O
good	good	JJ	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
but	but	CC	O	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
Cr	Cr	NNP	I-NP	O
checked	check	VBD	B-VP	O
after	after	IN	B-PP	O
starting	start	VBG	B-VP	O
the	the	DT	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
must	must	MD	B-VP	O
have	have	VB	I-VP	O
your	your	PRP$	B-NP	O
kidney	kidney	NN	I-NP	O
function	function	NN	I-NP	O
checked	check	VBD	B-VP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
make	make	VBP	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Shiley	Shiley	NNP	I-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
within	within	IN	B-PP	O
4-6	4-6	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
consider	consider	VB	B-VP	O
carefully	carefully	RB	B-ADVP	O
your	your	PRP$	B-NP	O
lifestyle	lifestyle	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
your	your	PRP$	B-NP	O
diet	diet	NN	I-NP	O
and	and	CC	I-NP	O
exercise	exercise	NN	I-NP	O
plans	plan	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
you	you	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
blockages	blockage	NNS	B-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
vessels	vessel	NNS	I-NP	O
requiring	require	VBG	B-VP	O
stenting	stente	VBG	B-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
started	start	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
blockages	blockage	NNS	B-NP	O
,	,	,	O	O
so	so	IN	O	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
thing	thing	NN	I-NP	O
you	you	PRP	B-NP	O
can	can	MD	B-VP	O
do	do	VB	I-VP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
slow	slow	VB	I-VP	O
this	this	DT	B-NP	O
process	process	NN	I-NP	O
down	down	RP	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
includes	include	VBZ	B-VP	O
losing	lose	VBG	I-VP	O
weight	weight	NN	B-NP	O
through	through	IN	B-PP	O
diet	diet	NN	B-NP	O
and	and	CC	I-NP	O
exercise	exercise	NN	I-NP	O
,	,	,	O	O
taking	take	VBG	B-VP	O
medications	medication	NNS	B-NP	O
including	include	VBG	B-PP	O
statin	statin	NN	B-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	B-protein
blocker	blocker	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
atenolol	atenolol	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
KOZATEK	KOZATEK	NNP	B-NP	O
,	,	,	O	O
EUSEBIO	EUSEBIO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TB9	TB9	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/9/04	9/9/04	CD	I-NP	O
@	@	NN	I-NP	O
06	06	CD	I-NP	O
:	:	:	O	O
39	39	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

